Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

OTC Antacid/Aspirin Bleeding Risk Raises Concerns At CDER

This article was originally published in The Tan Sheet

Executive Summary

CDER publishes a Drug Safety Communication, a consumer announcement and a MedWatch notice warning about the risk of serious bleeding when using OTC aspirin-containing antacid products.

Advertisement

Related Content

What’s Next For Antacid/Analgesic OTCs After Negative US FDA Panel?
Safety Review For Upset Stomach, Hangover OTCs Reconsiders Science
In Most Consumers' OTC Pain Relief Decisions, Safety Missing As A Factor
Loperamide Abuse Triggers Look At Potential Label Warning
FDA Expands Acetaminophen, NSAID Labeling Beyond Tentative Final Rule

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS108379

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel